Journal of Microwave Surgery
Online ISSN : 1882-210X
Print ISSN : 0917-7728
ISSN-L : 0917-7728
Long-term prognosis of patients with hepatocellular carcinoma who underwent thermal ablation therapies
Hiroki SakaguchiRitsuzo KozukaHiroyuki MotoyamaYasunori YamaguchiMika NakayaAi OeTakehiro HayashiHiroko KurookaHideki FujiiSawako KobayashiShuji IwaiHiroyasu MorikawaMasaru EnomotoAkihiro TamoriNorifumi Kawada
Author information
JOURNAL FREE ACCESS

2011 Volume 29 Pages 123-126

Details
Abstract

We analyzed the rates of survival and local recurrence among 89 patients with solitary hepatocellular carcinoma (HCC) who underwent thermal ablation therapies as primary treatment (naive patients). The number of patients was as follows; 35 cases in percutaneous radiofrequency ablation (RFA), 5 in laparoscopic RFA, 22 in percutaneous microwave coagulation therapy (MCT), and 54 in laparoscopic MCT. Five-year local recurrence rates were 40%, 50%, 50%, and 18% in percutaneous RFA, laparoscopic RFA, percutaneous MCT, and laparoscopic MCT, respectively, with no statistical significance. Rates of 5-year survival were 78%, 75%, 82%, and 70% in percutaneous RFA, laparoscopic RFA, percutaneous MCT, and laparoscopic MCT, respectively, with no statistical significance.
Thus, percutaneous RFA, laparoscopic RFA, percutaneous MCT, and laparoscopic MCT had same effectiveness for the local treatment of HCC.

Content from these authors
© 2011 Study Group of Microwave Surgery
Previous article Next article
feedback
Top